Biora Therapeutics. has been granted a patent for an ingestible device that autonomously identifies its location within the gastrointestinal tract. The device features optical sensing units and can release therapeutic agents based on its detected position, utilizing light reflection properties for location determination. GlobalData’s report on Biora Therapeutics gives a 360-degree view of the company including its patenting strategy. Buy the report here.
Smarter leaders trust GlobalData
According to GlobalData’s company profile on Biora Therapeutics, Ingestible drug delivery devices was a key innovation area identified from patents. Biora Therapeutics's grant share as of July 2024 was 29%. Grant share is based on the ratio of number of grants to total number of patents.
Ingestible device for locating and delivering therapeutic agents
The patent US12053271B2 describes an innovative ingestible device designed for therapeutic applications within the gastrointestinal (GI) tract. The device features a housing that contains a chamber for storing a therapeutic agent, an actuator that can switch between two states—one for storing the agent and another for releasing it—and a detector that identifies the device's location within the GI tract. A microcontroller processes the location data from the detector to control the actuator, facilitating the targeted delivery of the therapeutic agent. Additionally, the device includes one or more sensing sub-units that utilize light transmission and detection at two different wavelengths to monitor its environment and determine its position within the GI tract.
The device's light source can emit wavelengths from various spectra, including infrared, red, blue, and green, and may consist of components such as light-emitting diodes or RGB diode packages. The system generates data sets based on the detected light, allowing for the analysis of the device's movement through the GI tract. This capability is further enhanced by the inclusion of an array of detectors, which improves the accuracy of location detection. Overall, the patent outlines a sophisticated mechanism for delivering therapeutic agents in a controlled manner, leveraging advanced sensing technology to optimize treatment efficacy.
To know more about GlobalData’s detailed insights on Biora Therapeutics, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies
